ALDOSE REDUCTASE INHIBITORS - PHARMACOLOGICAL DATA AND THERAPEUTIC PERSPECTIVES

被引：4
作者：
CANAL, N [1 ]
COMI, G [1 ]
机构：
[1] UNIV MILAN,SCH MED,DEPT NEUROL,I-20132 MILANO,ITALY
来源：
TRENDS IN PHARMACOLOGICAL SCIENCES | 1985年 / 6卷 / 08期
关键词：
D O I：
10.1016/0165-6147(85)90152-X
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：328 / 330
页数：3
相关论文
共 21 条
[1]   DIABETIC NEUROPATHY [J].
BROWN, MJ ;
ASBURY, AK .
ANNALS OF NEUROLOGY, 1984, 15 (01) :2-12
[2]  
CANAL N, 1984, BR J CLIN PRAC S, V38, P62
[3]   DIABETIC NEUROPATHY - NEW CONCEPTS OF ITS ETIOLOGY [J].
CLEMENTS, RS .
DIABETES, 1979, 28 (06) :604-611
[4]   EFFECT OF AN ALDOSE REDUCTASE INHIBITOR ON DIABETIC PERIPHERAL NEUROPATHY - PRELIMINARY-REPORT [J].
CULEBRAS, A ;
ALIO, J ;
HERRERA, JL ;
LOPEZFRAILE, IP .
ARCHIVES OF NEUROLOGY, 1981, 38 (02) :133-134
[5]   POLYOL ACCUMULATION IN GALACTOSEMIC AND DIABETIC RATS - CONTROL BY AN ALDOSE REDUCTASE INHIBITOR [J].
DVORNIK, D ;
SIMARDDU.N ;
KRAMI, M ;
SESTANJ, K ;
GABBAY, KH ;
KINOSHITA, JH ;
VARMA, SD ;
MEROLA, LO .
SCIENCE, 1973, 182 (4117) :1146-1148
[6]  
FAGIUS J, 1981, J NEUROL NEUROSURG P, V44, P99
[7]   KINETICS OF AN ORALLY ABSORBED ALDOSE REDUCTASE INHIBITOR, SORBINIL [J].
FOULDS, G ;
OBRIEN, MM ;
BIANCHINE, JR ;
GABBAY, KH .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1981, 30 (05) :693-700
[8]   ALDOSE REDUCTASE INHIBITION - STUDIES WITH ALRESTATIN [J].
GABBAY, KH ;
SPACK, N ;
LOO, S ;
HIRSCH, HJ ;
ACKIL, AA .
METABOLISM-CLINICAL AND EXPERIMENTAL, 1979, 28 (04) :471-476
[9]   SORBITOL PATHWAY - PRESENCE IN NERVE AND CORD WITH SUBSTRATE ACCUMULATION IN DIABETES [J].
GABBAY, KH ;
MEROLA, LO ;
FIELD, RA .
SCIENCE, 1966, 151 (3707) :209-&
[10]   SORBITOL PATHWAY - ENZYME LOCALIZATION AND CONTENT IN NORMAL AND DIABETIC NERVE AND CORD [J].
GABBAY, KH ;
OSULLIVA.JB .
DIABETES, 1968, 17 (05) :239-&
123